TRANSCODE THERAPEUTICS INC (RNAZ) Stock Cash Flow
NASDAQ:RNAZ - Nasdaq - US89357L4023 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -25.51M | -16.75M | -18.55M | -17.57M | -6.84M | |||
| Depreciation Amortization | 553.90K | 534.90K | 123.50K | 98.60K | 42.50K | |||
| Change In Working Capital | 128.60K | -351.50K | -1.08M | 1.34M | 401.90K | |||
| Interest Paid | 10.90K | 16.60K | 32.90K | 37.10K | 17.90K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 12.34M | 3.24M | 1.43M | 364.80K | 1.13M | |||
| OPERATING CASH FLOW | -12.50M | -13.34M | -18.07M | -15.76M | -5.27M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -21.80K | -35.60K | -100.90K | -254.80K | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 3.00K | |||
| INVESTING CASH FLOW | N/A | -21.80K | -35.60K | -100.90K | -251.80K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 19.17M | 16.40M | 15.91M | 6.00K | 26.35M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | -831.70K | |||
| FINANCING CASH FLOW | 19.17M | 16.40M | 15.91M | 6.00K | 25.52M | |||
| CHANGE IN CASH | 6.66M | 3.04M | -2.20M | -15.86M | 20.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.50M | -13.34M | -18.07M | -15.76M | -5.27M | |||
| Capital Expenditure | N/A | -21.80K | -35.60K | -100.90K | -254.80K | |||
| FREE CASH FLOW | -12.51M | -13.36M | -18.11M | -15.86M | -5.52M | |||
All data in USD